Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19–Single-Center Experience
Tóm tắt
To describe the clinical presentation, phenotype and outcome of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) from a tertiary care center in southern India. 257 children fulfilling the inclusion criteria of MIS-C were prospectively enrolled from June, 2020 to March, 2022. Median (range) age at presentation was 6 year (35 day to 12 years). Presenting features were fever (98%), vomiting (75.8%), red eyes (63%), rashes (49%), pain abdomen (49%), shock (45.9%), lymphopenia (73%, thrombocytopenia (58.3%) and anemia (45%). 103 (39.7%) children required intensive care admission. Shock phenotype, Kawasaki-like phenotype and no specific phenotype were diagnosed in 45.9%, 44.4%, and 36.6% children, respectively. Left ventricular dysfunction (30.3%), acute kidney injury (13%), acute liver failure (17.4%), and hemophagolymphohistiocytosis (HLH) (13.6%) were the major system involvement in MIS-C. Mitral regurgitation (P=0.029), hyperechogenic coronaries (P=0.006), left ventricular dysfunction (P=0.001) and low ejection fraction (P=0.007) were significantly associated with shock. Overall mortality was 11.7%. Kawasaki-like and shock-like presentation were common in MIS-C. Coronary abnormalities were seen in 118 (45.9%) children. Children with acute kidney injury, HLH, need for mechanical ventilation, and echocardiogram evidence of mitral regurgitation in MIS-C have a poor outcome.
Tài liệu tham khảo
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief. 2020. Accessed February 6, 2022. Available from: https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
Jayashree M, Kulgod V, Sharma AK. Recognition of a sick child: A structured approach. In: Jayashree M, Kulgod V, Sharma AK, editors. IAP ALS Handbook. 2nd ed. Deepak Printographics; 2020. p.10–28.
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System (WHO/NMH/NHD/MNM/11.1). Accessed June 12, 2022. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138.
Alonso EM, Horslen SP, Behrens EM, Doo E. Pediatric acute liver failure of undetermined cause: A research workshop. Hepatology. 2017;65:1026–37.
Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009;127–31.
Pediatric Acute Lung Injury Consensus Conference Group. Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16:428–39.
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135: e927–99.
Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome–temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian Pediatr. 2020;57:1010–4.
Elilarasi S, Poovazhagi V, Kumaravel G, et al. Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Indian J Pediatr. 2022;89: 879–84.
Jain S, Sen S, Lakshmi Venkateshiah S, et al. Multisystem inflammatory syndrome in children with COVID-19 in Mumbai, India. Indian Pediatr. 2020;57:1015–9.
Anderson JE, Campbell JA, Durowoju L, et al. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock. J Pediatr Surg Case Rep. 2021;71:101913.
Muniz JC, Dummer K, Gauvreau K, et al. Coronary artery dimensions in febrile children without Kawasaki disease. Circ Cardiovasc Imaging. 2013;6:239–44.
Reyna J, Reyes LM, Reyes L, et al. Coronary artery dilation in children with febrile exanthematous illness without criteria for Kawasaki disease. Arq Bras Cardiol. 2019;113:1114–8.
Friedman KG, Harrild DM, Newburger JW. Cardiac dysfunction in multisystem inflammatory syndrome in children: A call to action. J Am Coll Cardiol. 2020;76:1962–4.
Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020; 142:429–36..
Acevedo L, Piñeres-Olave BE, Niño-Serna LF, et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with Covid-19 in critically ill patients: An observational multicenter study (MISCO study). BMC Pediatr. 2021;21:516.
Chandran J, James EJ, Verghese VP, Kumar TS, Sundaravalli EKR, Vyasam S. Clinical spectrum of children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Indian Pediatr. 2021;58:955–8.